Literature DB >> 16837495

Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab.

R C Chou, J W Henson, D Tian, E T Hedley-Whyte, A M Reginato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837495      PMCID: PMC1798234          DOI: 10.1136/ard.2005.042093

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

1.  Trastuzumab in CSF.

Authors:  B C Pestalozzi; S Brignoli
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

2.  Successful treatment of steroid-refractory neurosarcoidosis with infliximab.

Authors:  M Sollberger; F Fluri; T Baumann; S Sonnet; M Tamm; A J Steck; M Brutsche
Journal:  J Neurol       Date:  2004-06       Impact factor: 4.849

3.  Pachymeningeal thickening in rheumatoid arthritis.

Authors:  F Micheli; M C Scorticati; R Pikielny; C Zurru; E M Gatto
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

4.  Successful treatment of long-standing neuro-Behçet's disease with infliximab.

Authors:  Haroon Sarwar; Hugh McGrath; Luis R Espinoza
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

5.  Etanercept plus standard therapy for Wegener's granulomatosis.

Authors: 
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

Review 6.  The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.

Authors:  Marc C Hochberg; Mark G Lebwohl; Scott E Plevy; Kathryn F Hobbs; David E Yocum
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532

7.  Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide.

Authors:  A E Yücel; H Kart; P Aydin; A M Ağildere; S Benli; N Altinörs; B Demirhan
Journal:  Clin Rheumatol       Date:  2001       Impact factor: 2.980

8.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245

9.  Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.

Authors:  Eric T Wong; Roy Tishler; Loretta Barron; Julian K Wu
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

10.  Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.

Authors:  James L Rubenstein; Dan Combs; Jay Rosenberg; Arthur Levy; Michael McDermott; Lloyd Damon; Robert Ignoffo; Kenneth Aldape; Arthur Shen; Dana Lee; Antonio Grillo-Lopez; Marc A Shuman
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

View more
  12 in total

Review 1.  Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.

Authors:  Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima
Journal:  Clin Rheumatol       Date:  2020-04-30       Impact factor: 2.980

2.  Infliximab in the treatment of rheumatoid meningoencephalitis.

Authors:  Felix Luessi; Janina Sollors; Harald Müller; Peter Stoeter; Clemens Sommer; Thomas Vogt; Frank Birklein; Frank Thömke
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

Review 3.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

4.  Rheumatoid meningitis: a rare cause of unilateral pachymeningitis.

Authors:  Daniel Grose; Matthew Linger; Samara Tinni; Ramesh Sahathevan
Journal:  BMJ Case Rep       Date:  2019-04-03

Review 5.  Magnetic resonance imaging of rheumatoid meningitis: a case report and literature review.

Authors:  Zehra Isik Hasiloglu; Murat Asik; Burak Erer; Atilla Suleyman Dikici; Ayse Altintas; Sait Albayram
Journal:  Rheumatol Int       Date:  2011-09-08       Impact factor: 2.631

6.  Unusual central nervous system involvement of rheumatoid arthritis: successful treatment with steroid and azathioprine.

Authors:  Asuman Sengoz Inan; Seval Masatlıoglu; Seyfi C Ozyurek; Derya Engin; Ilknur Erdem
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

7.  An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis.

Authors:  Asli Kurne; Rana Karabudak; Omer Karadag; Gül Yalcin-Cakmakli; Kader Karli-Oguz; Kivilcim Yavuz; Meral Calgüneri; Mehmet Akif Topcuoglu
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

8.  Rheumatoid meningitis.

Authors:  María J Servioli; Chandril Chugh; John M Lee; José Biller
Journal:  Front Neurol       Date:  2011-12-26       Impact factor: 4.003

Review 9.  Rheumatoid meningitis: A case report and review of the literature.

Authors:  Zhaoyi Qin; June Kim; Damian Valencia; Lames Hamoodi; Jenna Neltner; Travis Sizemore; Robert Lightfoot
Journal:  Neurol Clin Pract       Date:  2020-02

10.  Rheumatoid Meningitis: Clinical Characteristics, Diagnostic Evaluation, and Treatment.

Authors:  Angela M Parsons; Fawad Aslam; Marie F Grill; Allen J Aksamit; Brent P Goodman
Journal:  Neurohospitalist       Date:  2019-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.